Akut limfoid leukémia (ALL): vizsgálatok itt: Egyesült Államok
194 of 230 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleInotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Where
- Aberdeen, Allentown, Alton, Anchorage, Ankeny, Ann Arbor, Arroyo Grande, Atlanta, Ballwin, Baltimore, Bellevue, Bellingham, Bend, Bethlehem, Birmingham, Bloomington, Boise, Bolivar, Branson, Brighton, Buffalo, Burbank, Burr Ridge, Canton, Cape Girardeau, Carbondale, Caro, Carson City, Carterville, Carthage, Centralia, Chadds Ford, Chapel Hill, Chelsea, Chicago, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Clive, Clovis, Columbus, Coos Bay, Creve Coeur, Decatur, Des Moines, Detroit, Dixon, Duarte, Durham, East China Township, East Stroudsburg, Eau Claire, Edmonds, Effingham, Eureka, Evanston, Everett, Farmington, Flint, Fort Lauderdale, Fort Smith, Fruitland, Galesburg, Garden City, Glenview, Great Bend, Greenville, Grosse Pointe Woods, Hazleton, Henderson, Highland Park, Homer Glen, Irvine, Issaquah, Jefferson City, Joplin, Jupiter, Kansas City, Kennewick, Kewanee, Kingman, Lacey, La Jolla, Lake Forest, Lake Success, Lansing, Las Vegas, Lewes, Livonia, Longview, Macomb, Madison, Manhasset, Marlette, Marshfield, Maywood, Melrose Park, Menomonee Falls, Meridian, Millville, Milwaukee, Minocqua, Missoula, Morgantown, Mount Vernon, Nampa, Newark, Newberg, New Berlin, New Hyde Park, New Lenox, New Orleans, New York, Oak Creek, O'Fallon, Oklahoma City, Omaha, Orange, Oregon City, Orland Park, Ottawa, Pahrump, Palo Alto, Pekin, Peoria, Peru, Philadelphia, Pontiac, Portland, Princeton, Redmond, Rehoboth Beach, Reno, Renton, Rice Lake, Richmond, Rochester, Rochester Hills, Rolla, Saginaw, Sainte Genevieve, Saint Joseph, Seaford, Seattle, Sedro-Woolley, Shelton, Springfield, Sterling Heights, Stevens Point, St Louis, Stony Brook, Sullivan, Tawas City, Twin Falls, Vancouver, Walla Walla, Warren, Washington, Washington D.C., Waukee, West Bend, West Branch, West Chester, Weston, Westwood, Wilmington, Winston-Salem, Yakima, Yelm, Ypsilanti
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03739814 - 1. fázisTaking peopleTesting the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Where
- Atlanta, Basking Ridge, City of Saint Peters, Columbus, Commack, Creve Coeur, Harrison, Middletown, Mineola, Montvale, New York, Richmond, St Louis, Uniondale
- Életkor
- 18 év and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04301076 - No phaseTaking peopleA Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Where
- Atlanta, Bethesda, Boston, Los Angeles, Salt Lake City, Seattle, Washington D.C.
- Életkor
- 1 év to 25 év
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05621291 - 2. fázisTaking peopleTesting the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Where
- Akron, Albany, Allentown, Anchorage, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boise, Boston, Buffalo, Chapel Hill, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Durham, El Paso, Fargo, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Louisville, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Morristown, Nashville, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Pittsburgh, Providence, Richmond, Roanoke, Rochester, Sacramento, San Antonio, San Francisco, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tampa, Temple, The Bronx, Toledo, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Worcester
- Életkor
- Up to 365 nap
- People
- 153 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06317662 - 1. fázisTaking peopleAnti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 57
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07572136 - 1/2. fázisTaking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winfield, Winston-Salem
- Életkor
- Up to 22 év
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - 4. fázisTaking peopleIdentification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Where
- Baton Rouge, Charlotte, Memphis, San Diego, Tulsa
- Életkor
- 1 év to 18 év
- People
- 850
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06289673 - 1. fázisTaking peopleThird-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 12
- Run by
- John Reneau
See details and how to joinNCT04848064 - 2. fázisTaking peopleDaratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL
- Where
- Chicago
- Életkor
- 18 év and over
- People
- 20
- Run by
- Eastern Cooperative Oncology Group
See details and how to joinNCT05289687 - 1. fázisTaking peopleA Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Where
- Atlanta, Aurora, Chicago, Cincinnati, Los Angeles, Palo Alto, Philadelphia, Salt Lake City, San Antonio, Seattle
- Életkor
- 0 év to 18 év
- People
- 30 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00 - 1/2. fázisTaking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Chicago, Duarte, Franklin, Houston, Iowa City, Jacksonville
- Életkor
- 12 év and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - 1. fázisTaking peopleGenetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
- Where
- Duarte, Irvine
- Életkor
- 18 év and over
- People
- 16
- Run by
- City of Hope Medical Center
See details and how to joinNCT07758673 - 1. fázisNot yet taking people in Egyesült ÁllamokMetabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic Leukemia
- Where
- Charleston
- Életkor
- 18 év and over
- People
- 18
- Run by
- Medical University of South Carolina
See details and how to joinNCT07896213 - 1. fázisTaking peopleAsciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)
- Where
- Chicago, Miami, New York, Seattle
- Életkor
- 18 év and over
- People
- 45
- Run by
- Sunil G. Iyer
See details and how to joinNCT07936266 - 2. fázisTaking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Akron, Albany, Albuquerque, Allentown, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Bridgeport, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Dearborn, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Martinsburg, Maywood, Mesa, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Newark, New Brunswick, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Parkersburg, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Sylvania, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Torrance, Traverse City, Troy, Tucson, Tulsa, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Wyoming, Yakima
- Életkor
- 1 év to 30 év
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - 1/2. fázisTaking peopleTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Where
- Charlotte, Hershey, Houston, Little Rock, Los Angeles, Madera, Minneapolis, New York, Norfolk, Orange, Orlando, Palo Alto, Phoenix, Portland, Salt Lake City, San Antonio, San Diego
- Életkor
- Up to 1 év
- People
- 90 worldwide
- Run by
- Tanja Andrea Gruber
See details and how to joinNCT05848687 - 3. fázisTaking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Cincinnati, Houston, Memphis, New York, Philadelphia
- Életkor
- 1 év to 64 év
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - 1. fázisNot yet taking people in Egyesült ÁllamokA Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- Where
- Houston
- Életkor
- 18 év and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07283640 - 2. fázisTaking peopleBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Where
- Houston
- Életkor
- 18 év and over
- People
- 90
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03263572 - 1/2. fázisTaking peoplePhase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Where
- Houston, The Bronx
- Életkor
- 18 év and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06308588 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Ann Arbor, Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St Louis
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisNot yet taking people in Egyesült ÁllamokA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
- Where
- New York
- Életkor
- 18 év to 55 év
- People
- 26
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07313852 - 1. fázisTaking peopleAzacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07388563 - 2. fázisNot yet taking people in Egyesült ÁllamokObesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
- Where
- Memphis
- Életkor
- 12 év to 24 év
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07790913 - 1. fázisNot yet taking people in Egyesült ÁllamokBLinatumomab and iNKT in Relapsed B-Cell ALL
- Where
- Chapel Hill
- Életkor
- 18 év and over
- People
- 13
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07869368